Citigroup Upgrades Core Laboratories to Neutral, Raises Price Target to $16
Benzinga Newsdesk 1 year ago
NewsUpgradesPrice TargetAnalyst Ratings
Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral and raises the price target from $15 to $16.
Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral and raises the price target from $15 to $16.